Related Experiment Video
Updated: Jan 18, 2026
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Dynamic changes of pulmonary function and immune function in children with mycoplasma pneumonia of different severity
Zheng Liu1,2,3,4,5, Wen Deng6, Wenlin Xu6
1Department of Respiratory, Children's Hospital of Chongqing Medical University, Chongqing, China.
Insights
Pulmonary and immune function changes in children with Mycoplasma pneumoniae pneumonia (MPP) indicate disease severity and recovery. These markers aid in personalized treatment strategies for pediatric MPP.
Area of Science:
- Pediatric Pulmonology
- Immunology
- Infectious Diseases
Background:
- Mycoplasma pneumoniae pneumonia (MPP) is a common childhood respiratory infection.
- Understanding the impact of MPP on lung and immune function is crucial for effective management.
Purpose of the Study:
- To investigate dynamic changes in pulmonary and immune function in pediatric MPP.
- To assess the utility of these markers in stratifying disease severity and predicting prognosis.
Main Methods:
- Retrospective cohort study of 225 pediatric patients with MPP.
- Measurement and comparison of lung function and immunological indices across severity groups.
Main Results:
- Children with MPP showed significant pulmonary function deficits and altered immune profiles.
- These functional changes correlated with both disease severity and patient recovery.
Conclusions:
- Pulmonary and immune markers are valuable for assessing severity and recovery in pediatric MPP.
- Clinical application of these markers can enhance individualized patient management.
Purpose:
To explore the dynamic changes in pulmonary and immune function among children with Mycoplasma pneumoniae pneumonia (MPP) and evaluate their value in disease severity stratification and prognosis prediction.
Method:
A retrospective cohort of 225 pediatric patients with varying degrees of MPP severity and disease course was analyzed. Lung function and immunological indices were measured and compared across groups.
Results:
Children with MPP exhibited significant impairments in pulmonary function and alterations in immune profiles compared to controls. These changes were associated with both disease severity and recovery status.
Conclusion:
Pulmonary and immune function markers may serve as useful indicators for assessing severity and recovery in pediatric MPP. Their clinical application could improve individualized management strategies.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:29Pneumonia II: Pathophysiology
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...